HRB
54
2
SEE
45
-4
DHI
45
2
AME
62
3
NAVI
43
16
AVGO
25
-2
BF.B
31
2
KMB
28
-5
DGX
33
-6
BRK.B
33
-3
HCP
47
-9
GS
52
-7
HAL
50
3
RF
53
-3
CCI
28
3
LYB
37
12
UNH
50
-5
PRGO
39
-4
CFG
52
-2
STX
52
2
HRB
54
2
SEE
45
-4
DHI
45
2
AME
62
3
NAVI
43
16
AVGO
25
-2
BF.B
31
2
KMB
28
-5
DGX
33
-6
BRK.B
33
-3
HCP
47
-9
GS
52
-7
HAL
50
3
RF
53
-3
CCI
28
3
LYB
37
12
UNH
50
-5
PRGO
39
-4
CFG
52
-2
STX
52
2
Financhill
Back

Theravance Biopharma Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Sell
47

TBPH
Theravance Biopharma

Last Price:
8.23
Seasonality Move:
11.3%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

Theravance Biopharma Price Quote

$8.23
+0.01 (+-0.6%)
(Updated: November 5, 2024 at 5:44 AM ET)

Theravance Biopharma Key Stats

Sell
47
Theravance Biopharma (TBPH) is a Sell
Day range:
$8.21 - $8.31
52-week range:
$7.44 - $11.71
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.59
P/B ratio:
2.08%
Volume:
80.1K
Avg. volume:
157.5K
1-year change:
-16.55%
Market cap:
$402.1M
Revenue:
$57.4M
EPS:
$-0.92

How Much Does Theravance Biopharma Make?

Is Theravance Biopharma Growing As A Company?

  • What Is Theravance Biopharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.04%
  • What Is Theravance Biopharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Theravance Biopharma Stock Price Performance

What Is Theravance Biopharma 52-Week High & Low?

Theravance Biopharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Theravance Biopharma?

Is Theravance Biopharma Cash Flow Positive?

  • What Is TBPH Cash Flow From Operations?
    Cash flow from operations (TTM) is -$8.8M
  • What Is Theravance Biopharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$63.8M
  • What Is Theravance Biopharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $13.3M

Theravance Biopharma Return On Invested Capital

  • Is Management Doing A Good Job?
    TBPH return on invested capital is -20.06%
  • What Is Theravance Biopharma Return On Assets?
    ROA measures how assets are converting to revenues and is -11.56%
  • What Is TBPH Return On Equity?
    ROE is a measure of profitability and is -20.06%

Theravance Biopharma Earnings Date & Stock Price

Theravance Biopharma Competitors

  • Who Are Theravance Biopharma's Competitors?
    Below is a list of companies who compete with Theravance Biopharma or are related in some way:
    • Biomarin Pharmaceutical Inc (BMRN)
    • Ionis Pharmaceuticals Inc (IONS)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Semler Scientific Inc (SMLR)

Theravance Biopharma Dividend Yield

Theravance Biopharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -85.71%
Revenue: 3.69% -6.87%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 13.20
Upside from Last Price: 60.58%

Major Shareholders

  • How many TBPH shares are owned by institutional investors?
    61M TBPH shares are owned by institutional investors
  • How many TBPH shares are owned by insiders?
    7.6M TBPH shares are owned by insiders